Scopolamine produces larger antidepressant and antianxiety effects in women than in men.
Ontology highlight
ABSTRACT: Some antidepressant agents generate differential benefit based on gender. Blocking cholinergic muscarinic receptors using scopolamine produces robust and rapid antidepressant effects in males and females combined. This study evaluated if males and females differ in the antidepressant response magnitude following scopolamine administration. A total of 52 male and female outpatients meeting criteria for recurrent major depressive or bipolar disorder participated in a double-blind, randomized, placebo-controlled, crossover clinical trial involving seven i.v. infusions of placebo or scopolamine (4 μg/kg). Following a single-blind placebo lead-in, participants entered either a placebo-block/scopolamine-block or a scopolamine-block/placebo-block sequence. Each block included three sessions. Clin
SUBMITTER: Furey ML
PROVIDER: S-EPMC3055321 | biostudies-literature | 2010 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA